Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Harbarth

Showing results (281-290 of 420) with videos related to

Pageof 42
Sort By:
BMJ Open|June 29, 2018
Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS)Gaud Catho, Marlieke De Kraker, Brigitte Waldispühl Suter, et al.
Open Forum Infectious Diseases|November 29, 2023
Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs FosfomycinRebecca Grant, Andrea Büchler, William Flight, et al.
British Journal of Clinical Pharmacology|December 14, 2011
The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settingsMamoon A Aldeyab, Stephan Harbarth, Nathalie Vernaz, et al.
Journal of Clinical Microbiology|October 15, 2010
Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureusSurbhi Malhotra-Kumar, Liesbet Van Heirstraeten, Andie Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infectionJacques Schrenzel, Stephan Harbarth, Gérard Schockmel, et al.
Antimicrobial Resistance and Infection Control|October 8, 2024
Increase in PVC-BSI during the second COVID-19 pandemic year: analysis of catheter and patient characteristicsEva Pianca, Marie-Céline Zanella, Basilice Minka Obama, et al.
Swiss Medical Weekly|July 15, 2021
Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitalsAliki Metsini, Andreas Widmer, Walter Zingg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 27, 2011
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and AustraliaCéline Pulcini, Karen Bush, William A Craig, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureusIlker Uçkay, Louis Bernard, Marta Buzzi, et al.
Infection|March 3, 2025
Increased incidence of blood culture contaminations during and after the COVID-19 pandemicHannah Tolle, Aude Nguyen, Aleece MacPhail, et al.
Pageof 42

Showing results (281-290 of 420) with videos related to

Sort By:
Pageof 42
BMJ Open|June 29, 2018
Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS)Gaud Catho, Marlieke De Kraker, Brigitte Waldispühl Suter, et al.
Open Forum Infectious Diseases|November 29, 2023
Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs FosfomycinRebecca Grant, Andrea Büchler, William Flight, et al.
British Journal of Clinical Pharmacology|December 14, 2011
The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settingsMamoon A Aldeyab, Stephan Harbarth, Nathalie Vernaz, et al.
Journal of Clinical Microbiology|October 15, 2010
Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureusSurbhi Malhotra-Kumar, Liesbet Van Heirstraeten, Andie Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infectionJacques Schrenzel, Stephan Harbarth, Gérard Schockmel, et al.
Antimicrobial Resistance and Infection Control|October 8, 2024
Increase in PVC-BSI during the second COVID-19 pandemic year: analysis of catheter and patient characteristicsEva Pianca, Marie-Céline Zanella, Basilice Minka Obama, et al.
Swiss Medical Weekly|July 15, 2021
Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitalsAliki Metsini, Andreas Widmer, Walter Zingg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 27, 2011
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and AustraliaCéline Pulcini, Karen Bush, William A Craig, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureusIlker Uçkay, Louis Bernard, Marta Buzzi, et al.
Infection|March 3, 2025
Increased incidence of blood culture contaminations during and after the COVID-19 pandemicHannah Tolle, Aude Nguyen, Aleece MacPhail, et al.
Pageof 42